CVS Group plc, a leading provider of veterinary services, has announced the appointment of David Wilton as the Non-executive Chair, effective from 1 May 2024. David, who has been an Independent Non-executive Director of the company since September 2021, brings over 30 years of experience as a Chief Financial Officer, Non-Executive Director, and consultant, with a background in corporate finance and regulatory processes. His appointment follows a comprehensive search by the Nomination Committee, supported by a blue-chip recruitment firm.
David Wilton's extensive experience in people businesses and regulatory processes, along with his technical expertise, is expected to support CVS in its strategic delivery of investment in technology. The Board expressed its gratitude to Deborah Kemp, the Group's Senior Independent Director, who has been acting as Interim Chair during the search period.
David Wilton expressed his enthusiasm, stating, "I am delighted to take on the role of Chair. I know the business well and I look forward to supporting the executive management team even more closely as we continue to grow the business and deliver value for all of our stakeholders." Richard Fairman, CEO, congratulated David on his appointment and thanked Deborah for her contribution during her position as Interim Chair.
CVS Group plc, an AIM-listed provider of veterinary services, operates in the UK, Australia, the Netherlands, and the Republic of Ireland. The company is focused on providing high-quality clinical services to its clients and their animals, with c.500 veterinary practices across its four territories, including specialist referral hospitals and dedicated out-of-hours sites. Additionally, CVS operates Laboratories, Crematoria, and an online retail business, Animed Direct.
The Board is committed to high standards of corporate governance and will commence a search for a new Independent Audit Committee Chair. David will remain as Audit Committee Chair until this process is completed, at which point he will then step down as a member of the Audit Committee. CVS Group plc's CEO, Richard Fairman, and Company Secretary, Scott Morrison, are the primary contacts for further information.
This news signifies a significant development for CVS Group plc, as David Wilton's appointment as Non-executive Chair is expected to bring valuable expertise and support to the company's strategic growth and investment plans.